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K e y  M e s s a g e s 
1. Perceived stigmatisation of patients with severe 
mental illness (SMI) was moderate and increased 
significantly over 1 year.
2. Patients’ perceptions of stigmatisation and their 
re-hospitalisation, together with mediating 
factors (eg patients’ functioning and self-esteem 
at recruitment, mental state, and family expressed 
emotion at 1-year follow-up) can predict illness 
relapse.
3. Development of community-based mental 
Perceived stigmatisation of patients with 
mental illness and its psychosocial correlates: a 
prospective cohort study
Introduction
People with mental illness have been stigmatised by 
the public as dangerous, violent, and unpredictable. 
Stigma is defined as social devaluation of people 
because of their personal attributes, leading to 
disgrace and social isolation.1 This biased attribution 
of misbehaviour and disgrace to people with mental 
illness is over-generalised.
 According to the attribution model and 
self-stigmatising hypothesis, the severity of the 
stigmatisation perceived by patients may lead to 
self-esteem decrement and at times predict illness 
relapse.2 Nonetheless, systematic assessment of the 
experiences of people with severe mental illness 
(SMI) and studies of stigma from the perspective of 
families and health professionals are limited. This 
study assessed patients’ perceived stigmatisation 
and its association with clinical, psychosocial, and 
psycho-pathological factors over 1 year.
 According to the stigmatising self-hypothesis,2 
two hypotheses on the relationships between 
patients’ perceived stigmatisation, re-hospitalisation 
rate, and other clinical and psychosocial factors 
were tested: (1) patients’ perceived stigmatisation 
correlates with family and health professionals’ 
attitudes toward SMI, their psychosocial health, 
and re-hospitalisation rate; (2) patients’ perceived 
stigmatisation predicts their re-hospitalisation 
after 1 year, as mediated by their psychosocial and 
clinical variables and the families’ and professionals’ 
attitudes toward them.
Methods
This prospective cohort study was conducted from 
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April 2010 to January 2012. Three groups of subjects: 
(1) randomly selected eligible adult patients, (2) the 
main family caregivers of the patients, and (3) mental 
health professionals of two public hospitals were 
invited to complete a questionnaire at the beginning 
and after 1 year. 
 Adult outpatients with SMI (schizophrenia, 
other psychotic disorders, and mood disorders for 
<5 years) were randomly selected, as were their main 
family caregivers. Assuming an attrition rate of 15%, 
a sample of 270 patients could achieve 90% power 
and an α=0.01 to detect a moderate effect size (mean 
difference/standard deviation) of 0.34 and was 
adequate for multiple linear regression (104+ total 
number of covariates).3 A total of 62 mental health 
professionals were recruited, including 18 nurses, 
eight psychiatrists, three occupational therapists, 
and two medical social workers.
 Primary outcome measures included the 
18-item Discrimination and Devaluation Scale 
(DDS), Specific Level of Functioning Scale, 
Chinese Rosenberg Self-Esteem Scale, Brief 
Psychiatric Rating Scale, and number and days 
of re-hospitalisations over the past 6 months. 
Secondary outcome measures consisted of the 
Chinese versions of Perceived Self-Efficacy Scale, 
Level of Expressed Emotion Scale, Family Burden 
Interview Schedule, Community Support Services 
Index, and professionals’ Stereotype and Restriction 
Scale.2,4 All scales demonstrated satisfactory internal 
consistency and construct validity.2,4
 A qualitative, exploratory approach was 
used to elicit patients’, family members’ and health 
professionals’ views on stigmatisation using focus 
group interviews. Six focus group interviews were 
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conducted with selected patients, family caregivers, 
and professionals independently (5-8 participants/
group) after the first assessment. Selection was made 
from those with the highest, median, and lowest 
DDS or Stereotype and Restriction Scale scores (2-3 
from each level).
 The correlations of the mean DDS scores of 
patients with other variables were examined. Chi-
square/Fisher’s exact test and independent T test 
were used to compare the mean DDS scores between 
categorical variables and changes in mean DDS 
scores and other continuous variables over 1 year, 
respectively. Multivariate regression and structural 
equation modelling technique were used to 
evaluate factors influencing the DDS scores and the 
hypothetical model predicting re-hospitalisations 
at the 1-year follow-up, respectively. Focus group 
interviews were transcribed and cross-checked for 
accuracy, followed by content analysis within and 
between groups by two independent assessors, 
contrasting the coding schemes and checking for 
inter-assessor agreement or reliability.
Results
Of 270 patients (and their family caregivers) who 
completed the questionnaire at the beginning 
(response rate, 84.4%), 238 completed the 
questionnaire at 1 year (attrition rate, 11.9%). 
Characteristics of patients and their caregivers were 
comparable between the 238 participants and the 
32 dropouts and between the two recruitment sites 
(Table 1). Of 62 health professionals, 32 (51.6%) had 
undertaken at least one community psychiatric care 
course; 52 (83.3%) had a bachelor/master degree, 
with a mean±standard deviation (SD) community 
care experience of 6.57±4.54 years.
 The mean DDS score was 55.03 (SD, 8.49; range 
37-78; possible range, 18-90) at the beginning and 
60.53 (SD, 9.17; range, 38-79) at 1 year, indicating 
a moderate level of stigmatisation perceived by 
patients and the level increased significantly after 
1 year. Patients significantly deteriorated in terms 
of functioning (196.60±21.79 vs 169.56±22.97), 
self-esteem (25.98±6.17 vs 22.13±5.01), length 
of re-hospitalisation (22.13±5.01 vs 12.48±7.08 
days/6 months), positive symptoms (2.90±2.17 vs 
3.45±2.30), overall burden (0.88±0.39 vs 0.95±0.32), 
and need for support services (2.99±3.29 vs 
3.49±2.51) [P=0.01-0.05]. Health professionals’ 
attitudes toward patients were slightly negative at 
the beginning and increased non-significantly at 
1 year (3.44±0.36 vs 3.52±0.57 for stereotype and 
2.43±0.44 vs 2.56±0.62 for restriction).
 The mean DDS scores at two time points 
correlated with most of the psychosocial variables, 
patient age, duration of illness, and number of 
psychiatric treatment received at the beginning (r/
rs=0.20-0.29, P=0.05-0.001). Similar levels of mean 
DDS scores were found among different types of 
SMI (P>0.1).
 Multiple regression analyses indicated that 
patients’ self-esteem, age, mental state, functioning, 
number of psychiatric treatments received (or length 
of re-hospitalisations at 1 year), and duration of 
illness (or expressed emotion at 1 year) accounted 
for 60.0% [F(10,235)=40.72, P<0.001; Cohen’s 
effect size f2=1.56] and 57.0% [F(10,235)=38.78 and 
P<0.002; Cohen’s f2=1.38] of the total variance in the 
perceived stigmatisation (large effect)3, respectively 
(Table 2). Of these variables, patients’ self-esteem, 
mental state, and age made the largest contributions. 
Different linear regression models were also tested. 
The best models indicated a large effect size (adjusted 
R2=0.50-0.72; large effect sizes with Cohen’s f2=0.67-
0.92).
 Structural modelling using maximum 
likelihood estimation supported the study hypothesis 
that patients’ DDS could predict the length of re-
hospitalisations at 1 year, mediated by patients’ age, 
functioning, self-esteem, and number of psychiatric 
treatments received at the beginning, and by their 
mental state and family expressed emotions at 1 year 
(Fig).
 Content analyses of the six focus group 
interviews resulted in four themes, including common 
emotional and behavioural responses towards 
SMI patients, possible reasons for stigmatisation, 
negative feelings about stigmatised experiences, 
and effective coping methods. Important messages 
on stigmatisation included: (1) the patients believed 
that stigmatisation occurred anytime and anywhere 
with negative verbal and behavioural expressions; 
(2) the main reasons for stigmatisation perceived 
by patients and professionals were very similar, 
including inadequate knowledge of mental illness, 
ineffective communication, and misunderstanding 
about their illness mostly learnt from relatives and the 
mass media; and (3) most patients expressed inferior 
and stressful feelings regarding recent experiences of 
stigmatisation; and (4) their effective ways of coping, 
including compliance with medication and regular 
follow-up, ignoring negative thoughts, explaining 
more to people about their illness, establishing 
better social support, and managing their emotions.
Discussion
In this study, the total DDS and self-esteem 
scores were relatively higher than those reported 
in a 2-year study of 88 psychiatric patients in 
the US.2 Nonetheless, our patients’ secrecy and 
withdrawal were relatively lower and caused less 
harm secondary to further social isolation and 
reinforcement of internalised stigmatisation.1,2,5 
Hong Kong patients demonstrated greater efforts 
to cope with stigmatisation of mental illness such as 
positively seeking social support from people, openly 
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* Data are presented as mean±SD or No. (%)
TABLE 1.  Characteristics of patients and family caregivers at baseline*
Characteristics Those who completed two assessments Those who dropped out at 1-year follow-up
Site A (n=118) Site B (n=120) Total (n=238) Site A (n=14) Site B (n=18) Total (n=32)
Patients
Female 72 (61.0) 78 (65.0) 150 (63.0) 9 (64.3) 11 (61.1) 20 (62.5)
Male 46 (39.0) 42 (35.0) 88 (37.0) 5 (35.7) 7 (38.9) 12 (37.5)
Age (years) 38.12±9.81 37.31±9.32 37.72±9.81 37.23±10.32 36.81±9.62 36.90±9.32
Education level
Primary school or below 16 (15.5) 15 (12.5) 31 (13.0) 2 (14.3) 3 (16.7) 5 (15.6)
Secondary school 88 (74.6) 89 (74.2) 177 (74.4) 10 (71.4) 13 (72.2) 23 (71.9)
Tertiary 14 (11.9) 16 (13.3) 30 (12.6) 2 (14.3) 2 (11.1) 4 (12.5)
Duration of mental illness (months) 33.2±14.23 31.83±12.02 32.31±12.82 31.84±12.02 32.31±13.52 31.81±14.02
Primary psychiatric diagnosis
Bipolar affective disorders 13 (11.0) 12 (10.0) 25 (10.5) 1 (7.1) 2 (11.1) 3 (9.4)
Psychotic disorders 23 (19.5) 24 (20.0) 47 (19.7) 3 (21.4) 4 (22.2) 7 (21.9)
Schizophrenia 44 (37.3) 46 (38.3) 90 (37.8) 5 (35.7) 6 (33.3) 11 (34.4)
Unipolar affective disorders (eg major depression) 28 (23.7) 26 (21.7) 54 (22.7) 3 (21.4) 4 (22.2) 7 (21.9)
Others (eg dual diagnoses) 10 (8.5) 12 (10.0) 22 (9.2) 2 (14.3) 2 (11.1) 4 (12.5)
No. of medical diseases 0.52±0.60 (0-4) 0.63±0.70 (0-5) 0.60±0.78 (0-5) 0.61±0.79 (0-3) 0.68±0.80 (0-4) 0.64±0.87 (0-4)
No. of family members living with patient 2.32±0.93 (0-4) 2.13±0.98 (0-5) 2.24±0.97 (0-5) 2.62±1.29 (1-5) 2.12±1.74 (0-5) 2.45±0.89 (0-5)
Psychiatric medications
Anti-depressants 36 40 76 (31.9) 3 (21.4) 5 (27.8) 8 (25.0)
Anti-convulsants 3 3 6 (2.5) 1 (7.1) 1 (5.6) 2 (6.3)
Atypical anti-psychotics 24 24 48 (20.2) 3 (21.4) 4 (22.2) 7 (21.9)
Conventional anti-psychotics 19 18 37 (15.5) 2 (14.3) 3 (16.7) 5 (15.6)
Lithium salts 3 3 6 (2.5) 1 (7.1) 1 (5.6) 2 (6.3)
Both anti-depressants and anti-psychotics 28 32 60 (25.2) 3 (21.4) 4 (22.2) 7 (21.9)
None 2 3 5 (2.1) 1 (7.1) 0 (0.0) 1 (3.1)
Re-hospitalisation in the past 6 months 
No. 0.49±0.41 0.51±0.37 0.50±0.48 0.50±0.42 0.54±0.37 0.52±0.45
Length (days) 9.12±4.18 10.08±5.33 9.82±6.88 8.51±5.78 9.48±3.77 8.90±3.15
No. of default follow-up in the past 6 months 0.20±0.24 0.28±0.27 0.22±0.25 0.22±0.29 0.29±0.36 0.25±0.31
No. of contact hours with caregivers per week 35.45±10.24 33.13±8.81 32.85±9.87 32.26±13.33 36.31±9.98 35.10±12.36
Psychiatric treatments
CPN visits and education 60 (50.8) 63 (52.5) 123 (51.7) 8 (57.1) 10 (55.6) 18 (56.3)
Family therapy/education 4 (3.4) 5 (4.2) 9 (3.8) 1 (7.1) 1 (5.6) 2 (6.3)
Medication compliance management 70 (59.3) 72 (61.0) 142 (59.7) 8 (57.1) 11 (61.1) 19 (59.4)
Psycho-education 80 (67.8) 78 (65.0) 158 (66.4) 9 (64.3) 9 (64.3) 18 (56.3)
Social and work skills training 41 (34.7) 44 (36.7) 85 (35.7) 5 (35.7) 5 (35.7) 10 (31.3)
Others (relaxation and self-regulation) 25 (21.2) 28 (23.3) 53 (22.6) 4 (28.6) 4 (28.6) 8 (25.0)
Family caregivers
Female 65 (55.6) 68 (57.1) 133 (56.4) 9 (60.0) 11 (57.9) 20 (58.8)
Male 52 (44.4) 51 (42.9) 103 (43.6) 6 (40.0) 8 (42.1) 14 (41.2)
Age (years) 45.21±10.02 47.45±9.77 46.78±12.23 40.53±10.55 48.05±11.56 46.90±10.96
Education level
Primary school or below 25 (21.4) 20 (16.8) 45 (19.1) 2 (13.3) 4 (21.1) 6 (17.7)
Secondary school 70 (59.8) 73 (61.3) 143 (60.6) 10 (66.7) 12 (63.2) 22 (64.6)
Tertiary 22 (18.8) 26 (21.9) 46 (19.5) 3 (20.03) 3 (15.8) 6 (17.7)
Relationship with patient
Child 25 (21.4) 23 (19.3) 48 (20.3) 3 (20.0) 4 (21.1) 7 (20.6)
Parent 38 (32.5) 39 (32.8) 77 (32.6) 5 (33.3) 5 (26.3) 10 (29.4)
Sibling 9 (7.7) 10 (8.4) 19 (8.1) 1 (6.7) 2 (10.5) 3 (8.8)
Spouse 41 (35.0) 43 (36.1) 84 (35.6) 5 (33.3) 7 (36.9) 12 (35.3)
Others 4 (3.4) 4 (3.4) 8 (3.4) 1 (6.7) 1 (5.3) 2 (5.9)
Monthly household income (HK$)
≤5000 6 (5.1) 7 (5.9) 13 (5.5) 1 (6.7) 2 (10.5) 3 (8.8)
5001-10 000 26 (22.2) 25 (21.0) 51 (21.6) 3 (20.0) 4 (21.1) 7 (20.6)
10 001-20 000 45 (38.5) 48 (40.3) 93 (39.4) 6 (40.0) 7 (36.8) 13 (38.2)
20 001-30 000 28 (23.9) 26 (21.8) 54 (22.9) 3 (20.0) 4 (21.1) 7 (20.6)
>30 000 12 (10.3) 13 (10.9) 25 (10.6) 2 (13.3) 2 (10.5) 4 (11.8)
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talking about the illness, and facing up to potentially 
stigmatising situations.
 Patients’ functioning, mental state, and self-
esteem were significantly worsened and their family’s 
overall caregiving burden, needs for community 
support services, and length of re-hospitalisations 
were significantly increased over 1 year. Mental 
health care providers should be aware of the negative 
longer-term effects of this perceived stigmatisation 
on community-dwelling SMI patients. Fortunately, 
the local health professionals’ stereotypes and 
restrictions toward these patients were lower than 
those in western studies and not correlated to the 
patients’ perceived stigmatisation. The mental 
health professionals in Hong Kong reported a high 
rate of acceptance of those with SMI.6 Perception 
of responsibility for a mental illness, together with 
myths of dangerousness and violence in people with 
SMI, may be culture-related and require further 
investigation.
 Patients’ symptom severity, psychosocial 
functioning, self-esteem, and duration of illness and 
family expressed emotions are associated with their 
own perceived stigmatisation.1,2 As indicated by the 
focus group interviews, the behavioural consequences 
of stigma (eg rejection and avoidance by others) 
affected most patients with SMI. Perceived stigma 
produced negative changes in feelings, attitudes, and 
behaviours for both the patients and family members 
at 1 year. High expressed emotion was associated with 
reported effects of perceived stigma in both patients 
TABLE 2.  Multiple regression analyses using the Discrimination and Devaluation Scale as the dependent variable
Variable β T df P value
Baseline
Rosenberg Self-Esteem Scale -0.17 -3.54 236 0.0008
Patient age 0.14 3.09 236 0.001
Brief Psychiatric Rating Scale 0.14 3.01 235 0.001
No. of psychiatric treatments received 0.13 2.49 235 0.005
Specific Level of Functioning Scale -0.12 -2.38 236 0.008
Duration of illness 0.11 2.26 236 0.01
Model summary: R2=0.82, adjusted R2=0.81, F=40.72, P<0.001
1 year
Rosenberg Self-Esteem Scale -0.18 -3.49 236 0.001
Brief Psychiatric Rating Scale 0.16 3.15 235 0.002
Length of re-hospitalisation 0.15 3.02 236 0.001
Specific Level of Functioning Scale -0.15 -3.00 235 0.001
Patient age 0.14 2.69 236 0.004
Level of Expressed Emotion Scale 0.12 2.25 236 0.01
Model summary: R2=0.81, adjusted R2=0.80, F=38.78, P<0.001
FIG.  Path diagram of perceived stigmatisation of patients with severe mental illness 
in predicting the length of re-hospitalisation at 1 year and mediating factors*
* With maximum likelihood estimation, the Discrimination and Devaluation Scale 
predicts the length of re-hospitalisation at 1 year: goodness-of-fit index CMIN/
df=1.529, df=412, P=0.0005, Tucker Lewis Index=0.916 (P>0.9), Comparative Fit 
Index=0.925 (P>0.9), Normed Fit Index=0.904 (P>0.9), and Root Mean Square 
Error of Approximation=0.047 (P<0.05) with 90% CI of 0.040-0.054
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and their families (such as lowered self-esteem and 
increased family burden), which is consistent with 
the perceived effect of stigma on schizophrenic 
patients and families in China.7 Perceived stigma of 
patients strongly affected their levels of perceived 
expressed emotion by family members. Therefore, 
directly addressing the perceived stigma and the 
destructive internalisation of negative self-images 
can decrease family members’ expressed emotion 
and in turn reduce patients’ relapse rates. The more 
chronic the course of the illness, the higher the 
patients’ perceived stigmatisation and thus the more 
they need treatments/services. Early educational 
intervention may minimise long-term undesirable 
effects in both patients and their families.
 Patients’ perceived stigmatisation was 
associated with the length of re-hospitalisation after 
1 year, as mediated by patients’ self-esteem and 
families’ expressed emotion. This is consistent with 
the key assumption of the modified labelling theory, 
namely that the stigma induced by being diagnosed/
labelled with a mental illness results in a spoiled 
identity,2 which is linked to negative psychosocial 
outcomes in terms of employment, self-esteem, 
and psychosocial functioning. Such negative 
consequences affect patients’ mental condition and 
contribute to their illness relapse.1,2 In addition, the 
patients’ mental state (or symptom severity) and 
self-esteem were associated with both the level of 
their perceived stigmatisation and re-hospitalisation 
at both time points. These two patient factors also 
affect the level of perceived stigmatisation and the 
course of illness.1
 Stigmatised patients may be denied access 
to important social roles.8 Nonetheless, in the 
focus group interviews, many patients were able to 
envisage stigma-coping strategies and avenues for 
positive change (such as good drug compliance and 
emotion management and establishing a better social 
support network). These strategies can help patients 
develop a sense of empowerment and enhance their 
self-esteem and ability to manage their daily lives.
 A few limitations of this study are worth 
noting. First, the study samples were recruited 
from two outpatient settings only and might not be 
representative. Second, the sample consisted of a 
high proportion of females (63%) in the two major 
illness groups (58% in schizophrenia and other 
psychotic disorders and 35% in affective disorders) 
and psychiatric nurses (60%) and thus could not 
fully reflect the gender patterns of these mental 
disorders8,12 or the composition of community 
mental health care teams in Hong Kong. Third, 
only important patient, family, and staff factors 
were selected for model testing; many potential 
confounders (such as medication compliance and 
social support) should have been included. Lastly, 
the illness relapse could have been measured by 
changes in symptom severity and non-adherence 
to treatment, not just by number and length of 
psychiatric re-hospitalisations.
 Patients’ perceived stigmatisation and number 
of re-hospitalisations can predict illness relapse of 
SMI patients. Development of valid measurement 
and design of effective interventions is needed.
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